Arias C, Acosta F, Bertocchini F, Fernandez-Arias C
Commun Biol. 2025; 8(1):446.
PMID: 40089642
DOI: 10.1038/s42003-025-07896-1.
Wu M, Wang H, Wu X, Zeng H, Miao M, Song Y
J Hepatocell Carcinoma. 2025; 12:467-480.
PMID: 40061164
PMC: 11887506.
DOI: 10.2147/JHC.S500638.
Huang L, Xie Y, Jiang S, Liu K, Ming Z, Shan H
Sci Rep. 2025; 15(1):2003.
PMID: 39814835
PMC: 11735813.
DOI: 10.1038/s41598-025-86052-5.
Zhai X, Yang R, Chu Q, Guo Z, Hou P, Li X
Nat Cell Biol. 2025; 27(1):141-153.
PMID: 39747579
DOI: 10.1038/s41556-024-01549-x.
Yi Y, Wang G, Zhang W, Yu S, Fei J, An T
Nat Commun. 2025; 16(1):212.
PMID: 39747079
PMC: 11695821.
DOI: 10.1038/s41467-024-55768-9.
Metabolic reprogramming in lung cancer and its clinical implication.
Huang Q, Fan L, Gong M, Ren J, Chen C, Xie S
Front Pharmacol. 2025; 15:1516650.
PMID: 39744129
PMC: 11688361.
DOI: 10.3389/fphar.2024.1516650.
PCK1 as a target for cancer therapy: from metabolic reprogramming to immune microenvironment remodeling.
Liu N, Zhu X, Wu C, Liu Y, Chen M, Gu J
Cell Death Discov. 2024; 10(1):478.
PMID: 39578429
PMC: 11584723.
DOI: 10.1038/s41420-024-02240-8.
Metabolic gatekeepers: harnessing tumor-derived metabolites to optimize T cell-based immunotherapy efficacy in the tumor microenvironment.
Zheng Y, Xu R, Chen X, Lu Y, Zheng J, Lin Y
Cell Death Dis. 2024; 15(10):775.
PMID: 39461979
PMC: 11513100.
DOI: 10.1038/s41419-024-07122-6.
The signature of extracellular vesicles in hypoxic breast cancer and their therapeutic engineering.
Zhu B, Xiang K, Li T, Li X, Shi F
Cell Commun Signal. 2024; 22(1):512.
PMID: 39434182
PMC: 11492701.
DOI: 10.1186/s12964-024-01870-w.
Glutamine Metabolism and Prostate Cancer.
Erb H, Polishchuk N, Stasyk O, Kahya U, Weigel M, Dubrovska A
Cancers (Basel). 2024; 16(16).
PMID: 39199642
PMC: 11352381.
DOI: 10.3390/cancers16162871.
Targeting the glutamine-arginine-proline metabolism axis in cancer.
Wang D, Duan J, Guo Y, Chen J, Chen T, Wang J
J Enzyme Inhib Med Chem. 2024; 39(1):2367129.
PMID: 39051546
PMC: 11275534.
DOI: 10.1080/14756366.2024.2367129.
Harnessing CD8 T cell dynamics in hepatitis B virus-associated liver diseases: Insights, therapies and future directions.
Yue B, Gao Y, Hu Y, Zhan M, Wu Y, Lu L
Clin Transl Med. 2024; 14(7):e1731.
PMID: 38935536
PMC: 11210506.
DOI: 10.1002/ctm2.1731.
Stable Isotope Tracing Analysis in Cancer Research: Advancements and Challenges in Identifying Dysregulated Cancer Metabolism and Treatment Strategies.
Hilovsky D, Hartsell J, Young J, Liu X
Metabolites. 2024; 14(6).
PMID: 38921453
PMC: 11205609.
DOI: 10.3390/metabo14060318.
Elevated SLC1A5 associated with poor prognosis and therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma.
Zhang G, Xiao Y, Tan J, Liu H, Fan W, Li J
J Transl Med. 2024; 22(1):543.
PMID: 38844930
PMC: 11157896.
DOI: 10.1186/s12967-024-05298-1.
Association between human blood metabolites and cerebral cortex architecture: evidence from a Mendelian randomization study.
Jiang Z, Sun Y, Liu S
Front Neurol. 2024; 15:1386844.
PMID: 38784905
PMC: 11111910.
DOI: 10.3389/fneur.2024.1386844.
Reprogramming of Lipid Metabolism Mediates Crosstalk, Remodeling, and Intervention of Microenvironment Components in Breast Cancer.
Wang J, Zhang W, Liu C, Wang L, Wu J, Sun C
Int J Biol Sci. 2024; 20(5):1884-1904.
PMID: 38481820
PMC: 10929185.
DOI: 10.7150/ijbs.92125.
Metabolic collaboration between cells in the tumor microenvironment has a negligible effect on tumor growth.
Gustafsson J, Roshanzamir F, Hagnestal A, Patel S, Daudu O, Becker D
Innovation (Camb). 2024; 5(2):100583.
PMID: 38445018
PMC: 10912649.
DOI: 10.1016/j.xinn.2024.100583.
CYB561 promotes HER2+ breast cancer proliferation by inhibiting H2AFY degradation.
Zhao T, Wang C, Zhao N, Qiao G, Hua J, Meng D
Cell Death Discov. 2024; 10(1):38.
PMID: 38245506
PMC: 10799939.
DOI: 10.1038/s41420-024-01804-y.
Glycolysis Reprogramming in Idiopathic Pulmonary Fibrosis: Unveiling the Mystery of Lactate in the Lung.
Yan P, Liu J, Li Z, Wang J, Zhu Z, Wang L
Int J Mol Sci. 2024; 25(1).
PMID: 38203486
PMC: 10779333.
DOI: 10.3390/ijms25010315.
PRUNE1 and NME/NDPK family proteins influence energy metabolism and signaling in cancer metastases.
Ferrucci V, Lomada S, Wieland T, Zollo M
Cancer Metastasis Rev. 2024; 43(2):755-775.
PMID: 38180572
PMC: 11156750.
DOI: 10.1007/s10555-023-10165-4.